Abstract
Antimicrobial peptide CM4 is a small cationic peptide with broad-spectrum activities against bacteria, fungi, and tumor cells. Different strategies have been developed to produce small antibacterial peptides using recombinant techniques. To date, no efforts to obtain large quantities of active recombinant CM4 have been reported. In order to establish a bacterium-based CM4 production system, CM4 was cloned into pET28a and expressed with Npro mutant (EDDIE) fusion. CM4 expressed as EDDIE are deposited as inclusion bodies. On in vitro refolding by switching from chemotropic to kosmotropic conditions, the fusion partner is released from the C-terminal end of the autoprotease by self-cleavage, leaving CM4 protein with an authentic N terminus. Purified CM4 was separated on Ni2+-chelating chromatography column and cation-exchange chromatography column. Mass spectroscopic analysis indicated the protein to be 4132.56 Dalton, which equalled the theoretically expected mass. N-terminal sequencing of CM4 showed the sequence corresponded to the native protein. The recombinant CM4 exhibited the same antimicrobial and anti-tumor activity as reported previously. The expression strategy presented in this study allows convenient high yield and easy purification of recombinant CM4 with native sequences.
Similar content being viewed by others
References
Barrell PJ, Liew OW, Conner AJ (2004) Expressing an antibacterial protein in bacteria for raising antibodies. Protein Expr Purif 33:153–159. doi:10.1016/j.pep.2003.08.026
Boix E, Wu Y, Vasandani VM, Saxena SK, Ardelt W, Ladner J (1996) Role of the N terminus in RNase A homologues: differences in catalytic activity, ribonucleaseinhibitor interaction and cytotoxicity. J Mol Biol 257(5):992–1007. doi:10.1006/jmbi.1996.0218
Bulet P, Stocklin R, Menin L (2004) Anti-microbial peptides:from invertebrates to vertebrates. Immunol Rev 198:169–184. doi:10.1111/j.0105-2896.2004.0124.x
Chen YQ, Zhang SQ, Li BC, Qiu W (2008) Expression of a cytotoxic cationic antibacterial peptide in Escherichia coli using two fusion partners. Protein Expr Purif 57:303–311. doi:10.1016/j.pep.2007.09.012
Clemens A, Waltraud K, Karin A (2007) Npro fusion technology to produce proteins with authentic N termini in E. coli. Nat Methods 4(12):1037–1043. doi:10.1038/nmeth1116
Fang X, Peng L, Xu Z, Wu J, Cen P (2002) Cloning and expression of human beta-defensin-2 gene in Escherichia coli. Protein Pept Lett 9:31–37. doi:10.2174/0929866023409011
Greenwood D (1998) Resistance to antimicrobial agents: a personal view. J Med Microbiol 47:751–755
Hancock RE (2001) Cationic peptides: effectors in innate immunity and novel antimicrobials. Lancet Infect Dis 1:156–164. doi:10.1016/S1473-3099(01)00092-5
Jia H, Zhang S, Dai Z (1996) Studies on the killing action of the antibacterial peptides on cancer cells and their influence on the ultrastructure. Zool Res 3:258–264
Lee JH, Minn I, Chan B, Park Sun C, Kim I (1998) Acidic peptidemediated expression of the antimicrobial peptide Buforin II as tandem repeats in Escherichia coli. Protein Expr Purif 2:53–60. doi:10.1006/prep.1997.0814
Li B, Zhang S (2007) Expression in Escherichia coli and purification of bioactiveantibacterial peptide ABP-CM4 from the Chinese silkworm, Bombyx mori. Biotechnol Lett 29:1031–1036. doi:10.1007/s10529-007-9351-4
Li Y, Li X, Wang G (2006) Cloning expression isotope labeling and purification of human antimicrobial peptide LL-37 in Escherichia coli for NMR studies. Protein Expr Purif 47:498–505. doi:10.1016/j.pep.2005.10.022
Pyo SH, Lee JH, Park HB, Cho JS, Kim HR, Han BH (2004) Expression and purification of a recombinant buforin derivative from Escherichia coli. Proc Biochem 39:1731–1736. doi:10.1016/j.procbio.2003.07.007
Rao X, Li S, Hu J, Jin X, Hu X, Huang J, Chen Z, Zhu J (2004) A novel carrier molecule for high-level expressionof peptide antibiotics in Escherichia coli. Protein Expr Purif 36:11–18. doi:10.1016/j.pep.2004.01.020
Rene U, Astrid D, Karin A, Sabrina M, Wolfgang S (2009) EDDIE fusion proteins: triggering autoproteolytic cleavage. Pro Biochem 44:1217–1224. doi:10.1016/j.procbio.2009.06.017
Skosyrev VS, Rudenko NV, Yakhnin AV, Zagranichny VE, Popova LI, Zakharov MV, Gorokhovatsky AY (2003) EGFP as a fusion partner for the expression and organic extraction ofsmall polypeptides. Protein Expr Purif 27:55–62. doi:10.1016/S1046-5928(02)00595-8
Snary EL, Kelly LA, Davison HC et al (2004) Antimicrobial resistance: a microbial risk assessment perspective. J Antimicrob Hemother 53:906–917. doi:10.1093/jac/dkh182
Stark R, Meyers G, Rumenapf T, Thiel HJ (1993) Processing of pestivirus polyprotein: cleavage site between autoprotease and nucleocapsid protein of classical swine fever virus. J Virol 67:7088–7095. doi:0022-538X/93/127088-08$02.00/0
Zasloff M (2002) Antimicrobial peptides of multicellular organisms. Nature 415:389–395. doi:10.1038/415389a
Zeng TY, Zhang S, Qu X (1989) Separation, purification of antibacterial CM4 and the research of the structure and character. Sci China B 32:473–480
Zhang SQ, Dai ZY (1997) Ultrastructure observation of K562 leukemia cells treated with antibacterial peptide CM4 component. Prog Biochem Biophys 24:159–163
Zhang L, Falla T, Wu M, Fidai S, Burian J, Kay W, Hancock RE (1998) Determinants of recombinant production of antimicrobial cationic peptides and creation of peptide variants in bacteria. Biochem Biophys Res Commun 247:674–680. doi:10.1006/bbrc.1998.8848
Zhou LF, Zhao ZH, Li BC, Cai YF, Zhang SQ (2009) TrxA m ediating fusion expression of antimicrobial peptide CM4 from multiple joined genes in Escherichia coli. Protein Expr Purif 64:225–230. doi:10.1016/j.pep.2008.11.006
Acknowledgments
We thank Dr. Bernhard Auer, Institute of Biochemistry, University of Innsbruck, Austria, for kindly providing us with vector pET30/EDDIE. This research was supported by the grant from Jiangsu Province’s Outstanding Leader Program of Traditional Chinese Medicine.
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
About this article
Cite this article
Cheng, X., Lu, W., Zhang, S. et al. Expression and purification of antimicrobial peptide CM4 by Npro fusion technology in E. coli . Amino Acids 39, 1545–1552 (2010). https://doi.org/10.1007/s00726-010-0625-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00726-010-0625-0